8-K/A: OneMedNet Corporation Amends 8-K to Include Legacy Financials After Business Combination

OneMedNet Corporation filed an amendment to its original 8-K report to include the consolidated financial statements of Legacy OneMedNet for the three and nine months ended September 30, 2023, and related management analysis.

Summary

• OneMedNet Corporation has amended its initial 8-K filing to incorporate the financial results of Legacy OneMedNet for the period ending September 30, 2023.
• The amendment includes the consolidated financial statements and management's discussion and analysis for the three and nine months ended September 30, 2023.
• This filing is solely to add the historical financials of Legacy OneMedNet and does not reflect any updates or developments at the company since the original report.
• The company's financials show a net loss of $31.2 million for the nine months ended September 30, 2023, compared to a net loss of $22.4 million for the same period in 2022.
• The company's cash balance was $0.6 million as of September 30, 2023, which is not sufficient to fund operations for the next 12 months.
• The company is planning to raise additional capital through equity or debt offerings to continue operations.

Sentiment

Score: 3

Explanation: The document reveals significant financial challenges, including substantial losses, declining revenue in a key segment, and a going concern warning, which indicates a negative outlook from an investment perspective.

Positives

• Subscription revenue increased by 19% for the nine months ended September 30, 2023, indicating growth in that segment.
• The company reduced its cost of revenue as a percentage of revenue by 5% for the nine months ended September 30, 2023.
• General and administrative expenses decreased by 38% for the nine months ended September 30, 2023, showing improved cost management.

Negatives

• The company experienced a significant net loss of $31.2 million for the nine months ended September 30, 2023.
• Web imaging revenue decreased by 78% for the nine months ended September 30, 2023, indicating a significant decline in that revenue stream.
• The company's cash balance of $0.6 million is insufficient to fund operations for the next 12 months.
• Total revenue decreased by 23% for the nine months ended September 30, 2023.

Risks

• The company's ability to continue as a going concern is in doubt due to recurring losses and insufficient cash reserves.
• The company is dependent on raising additional capital through equity or debt offerings, which may not be secured in a timely manner or on favorable terms.
• Existing stockholders may experience dilution if the company issues equity securities to raise additional funds.
• The company's financial results are subject to risks common to companies in the markets it serves, including global economic conditions and competition.

Future Outlook

The company plans to raise additional working capital through an equity or debt offering and ultimately attain profitable operations to fulfill its operating and capital requirements for at least 12 months from the date of the issuance of the consolidated financial statements.

Management Comments

• Management plans to raise additional working capital through an equity or debt offering.
• Management believes that the company's non-GAAP financial measure, Adjusted EBITDA, reflects the ongoing business in a manner that allows for meaningful comparisons and analysis of trends in the business.

Industry Context

The company operates in the healthcare software industry, providing solutions for digital medical image management, exchange, and sharing. The company's performance is affected by factors such as customer demand, technological innovations, and competition.

Comparison to Industry Standards

• The document does not provide specific details on comparable companies or projects.
• The company's financial performance, particularly the significant net loss and declining web imaging revenue, suggests it is underperforming compared to industry benchmarks.
• The company's reliance on external funding and its going concern status indicate a weaker financial position than many established players in the healthcare software sector.

Management Changes

Related Party Transactions

• The company issued various Convertible Promissory Notes to related party investors, totaling $12.3 million in gross proceeds.
• The company issued 2,976,000 shares of Convertible Promissory Note Warrants to related parties.
• The company entered into shareholder loans with related party investors for aggregate gross proceeds of $704,000.
• The company received gross proceeds of $2.0 million in connection with shareholder loans with related party investors in 2024.

Stakeholder Impact

• Shareholders may experience dilution due to potential equity offerings.
• Employees may be affected by the company's financial instability.
• Customers may be concerned about the company's ability to continue providing services.
• Creditors may be at risk due to the company's financial difficulties.

Next Steps

• The company needs to secure additional financing through equity or debt offerings.
• The company needs to improve its financial performance and reduce its losses.
• The company needs to address the going concern issue.

Key Dates

Keywords

financial statements, OneMedNet, Legacy OneMedNet, business combination, revenue, net loss, cash flow, subscription revenue, web imaging revenue, convertible debt, going concern, capital raise